Literature DB >> 16024817

Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences.

David C King1, James Taylor, Laura Elnitski, Francesca Chiaromonte, Webb Miller, Ross C Hardison.   

Abstract

Techniques of comparative genomics are being used to identify candidate functional DNA sequences, and objective evaluations are needed to assess their effectiveness. Different analytical methods score distinctive features of whole-genome alignments among human, mouse, and rat to predict functional regions. We evaluated three of these methods for their ability to identify the positions of known regulatory regions in the well-studied HBB gene complex. Two methods, multispecies conserved sequences and phastCons, quantify levels of conservation to estimate a likelihood that aligned DNA sequences are under purifying selection. A third function, regulatory potential (RP), measures the similarity of patterns in the alignments to those in known regulatory regions. The methods can correctly identify 50%-60% of noncoding positions in the HBB gene complex as regulatory or nonregulatory, with RP performing better than do other methods. When evaluated by the ability to discriminate genomic intervals, RP reaches a sensitivity of 0.78 and a true discovery rate of approximately 0.6. The performance is better on other reference sets; both phastCons and RP scores can capture almost all regulatory elements in those sets along with approximately 7% of the human genome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024817      PMCID: PMC1182217          DOI: 10.1101/gr.3642605

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  99 in total

1.  The ENCODE (ENCyclopedia Of DNA Elements) Project.

Authors: 
Journal:  Science       Date:  2004-10-22       Impact factor: 47.728

2.  Roles of fetal G gamma-globin promoter elements and the adult beta-globin 3' enhancer in the stage-specific expression of globin genes.

Authors:  C Perez-Stable; F Costantini
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

3.  Identification of a transcriptional silencer in the 5'-flanking region of the human epsilon-globin gene.

Authors:  S X Cao; P D Gutman; H P Dave; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  An erythroid-specific, developmental-stage-independent enhancer far upstream of the human "beta-like globin" genes.

Authors:  D Y Tuan; W B Solomon; I M London; D P Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Distinct negative regulation of the human embryonic globin genes zeta and epsilon.

Authors:  P Watt; P Lamb; N J Proudfoot
Journal:  Gene Expr       Date:  1993

6.  Characterization of the DNase I hypersensitive site 3' of the human beta globin gene domain.

Authors:  D E Fleenor; R E Kaufman
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

7.  The regulated expression of beta-globin genes introduced into mouse erythroleukemia cells.

Authors:  M V Chao; P Mellon; P Charnay; T Maniatis; R Axel
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

8.  A single erythroid-specific DNase I super-hypersensitive site activates high levels of human beta-globin gene expression in transgenic mice.

Authors:  T M Ryan; R R Behringer; N C Martin; T M Townes; R D Palmiter; R L Brinster
Journal:  Genes Dev       Date:  1989-03       Impact factor: 11.361

9.  DNA sequences involved in transcriptional regulation of the mouse beta-globin promoter in murine erythroleukemia cells.

Authors:  A Cowie; R M Myers
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

10.  Developmental regulation of the human embryonic beta-like globin gene is mediated by synergistic interactions among multiple tissue- and stage-specific elements.

Authors:  W L Trepicchio; M A Dyer; M H Baron
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

View more
  117 in total

1.  Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study.

Authors:  Sílvia Oliveira; Ana Paula Ardais; Clarissa Ribeiro Bastos; Marta Gazal; Karen Jansen; Luciano de Mattos Souza; Ricardo Azevedo da Silva; Manuella Pinto Kaster; Diogo Rizzato Lara; Gabriele Ghisleni
Journal:  Purinergic Signal       Date:  2018-12-03       Impact factor: 3.765

2.  A liver enhancer in the fibrinogen gene cluster.

Authors:  Alexandre Fort; Richard J Fish; Catia Attanasio; Roland Dosch; Axel Visel; Marguerite Neerman-Arbez
Journal:  Blood       Date:  2010-10-04       Impact factor: 22.113

3.  Identification and characterization of Hoxa9 binding sites in hematopoietic cells.

Authors:  Yongsheng Huang; Kajal Sitwala; Joel Bronstein; Daniel Sanders; Monisha Dandekar; Cailin Collins; Gordon Robertson; James MacDonald; Timothee Cezard; Misha Bilenky; Nina Thiessen; Yongjun Zhao; Thomas Zeng; Martin Hirst; Alfred Hero; Steven Jones; Jay L Hess
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

4.  Discover regulatory DNA elements using chromatin signatures and artificial neural network.

Authors:  Hiram A Firpi; Duygu Ucar; Kai Tan
Journal:  Bioinformatics       Date:  2010-05-07       Impact factor: 6.937

5.  Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.

Authors:  David T Dao; Pamela Belmonte Mahon; Xiang Cai; Colleen E Kovacsics; Robert A Blackwell; Michal Arad; Jianxin Shi; Peter P Zandi; Patricio O'Donnell; James A Knowles; Myrna M Weissman; William Coryell; William A Scheftner; William B Lawson; Douglas F Levinson; Scott M Thompson; James B Potash; Todd D Gould
Journal:  Biol Psychiatry       Date:  2010-08-17       Impact factor: 13.382

6.  Small noncoding differentially methylated copy-number variants, including lncRNA genes, cause a lethal lung developmental disorder.

Authors:  Przemyslaw Szafranski; Avinash V Dharmadhikari; Erwin Brosens; Priyatansh Gurha; Katarzyna E Kolodziejska; Ou Zhishuo; Piotr Dittwald; Tadeusz Majewski; K Naga Mohan; Bo Chen; Richard E Person; Dick Tibboel; Annelies de Klein; Jason Pinner; Maya Chopra; Girvan Malcolm; Gregory Peters; Susan Arbuckle; Sixto F Guiang; Virginia A Hustead; Jose Jessurun; Russel Hirsch; David P Witte; Isabelle Maystadt; Neil Sebire; Richard Fisher; Claire Langston; Partha Sen; Paweł Stankiewicz
Journal:  Genome Res       Date:  2012-10-03       Impact factor: 9.043

Review 7.  Determining causality and consequence of expression quantitative trait loci.

Authors:  A Battle; S B Montgomery
Journal:  Hum Genet       Date:  2014-04-26       Impact factor: 4.132

8.  A misplaced lncRNA causes brachydactyly in humans.

Authors:  Philipp G Maass; Andreas Rump; Herbert Schulz; Sigmar Stricker; Lisanne Schulze; Konrad Platzer; Atakan Aydin; Sigrid Tinschert; Mary B Goldring; Friedrich C Luft; Sylvia Bähring
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

9.  Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure.

Authors:  Matthew R G Taylor; Dobromir Slavov; Kurt Humphrey; Lan Zhao; Jennifer Cockroft; Xiao Zhu; Philip Lavori; Michael R Bristow; Luisa Mestroni; Laura C Lazzeroni
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

10.  Histone modifications at human enhancers reflect global cell-type-specific gene expression.

Authors:  Nathaniel D Heintzman; Gary C Hon; R David Hawkins; Pouya Kheradpour; Alexander Stark; Lindsey F Harp; Zhen Ye; Leonard K Lee; Rhona K Stuart; Christina W Ching; Keith A Ching; Jessica E Antosiewicz-Bourget; Hui Liu; Xinmin Zhang; Roland D Green; Victor V Lobanenkov; Ron Stewart; James A Thomson; Gregory E Crawford; Manolis Kellis; Bing Ren
Journal:  Nature       Date:  2009-03-18       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.